BIMAST score vs FIB-4 for predicting significant and advanced fibrosis in the Sicilian cohort. by Roberta Forlano (9499666)

Most significant muscle activation values. by María Benito-de-Pedro (22057468)

Subjects:

BIMAST score vs FIB-4 for predicting significant and advanced fibrosis in the Royal Free cohort. by Roberta Forlano (9499666)

Significant repeated measurements sEMG outcomes. by María Benito-de-Pedro (22057468)

Subjects:

Significant single measurement sEMG outcomes. by María Benito-de-Pedro (22057468)

Subjects:

Diagnostic performance of the BIMAST score for predicting significant and advanced fibrosis in the derivation cohort (diabetes primary care). by Roberta Forlano (9499666)

Overview of the WeARTolerance program. by Ana Beato (20489933)

“…<div><p>The stigma surrounding mental health remains a significant barrier to help-seeking and well-being in youth populations. …”

Table 1_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

“…The frequency of T-regulatory cells (CD4+CD25+Foxp3+, Tregs) declined also in the advanced MASLD patients (3.57%) compared to the early stage disease (5.16%). …”

Table 2_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

“…The frequency of T-regulatory cells (CD4+CD25+Foxp3+, Tregs) declined also in the advanced MASLD patients (3.57%) compared to the early stage disease (5.16%). …”

Risk Factors related to Frailty in patients with advanced chronic kidney disease. by Rocio Gimena Muñoz (22339634)

Subjects:

Foslevodopa/Foscarbidopa: A Review in Advanced Parkinson’s Disease by Hannah A. Blair (13864794)

“…It is approved for the treatment of motor fluctuations in patients with advanced Parkinson’s disease (PD). Administered via an ambulatory infusion pump, it allows for personalized dosing based on individual needs. …”

Significantly Enriched Pathways. by Jiyong Zhang (2498740)

“…By comparing samples from NAFLD patients and healthy controls, we identified 1,770 significant DEGs, with 1,073 being upregulated and 697 downregulated. …”

Significant differentially expressed genes dataset. by MaoMeng Wang (22177417)

Subjects:

Significant Decrease in Vessel Count of Trade Vessels in (a) Bosporus Strait and (b) Bab el-Mandeb Strait. by Cherryl Chico (20978829)

Data Extraction Sheet: A sheet that contains the data that we extracted from the included studies. by Mohamed R. Abdelraouf (21501468)

Multivariate predictive model of Frailty with total microvesicles in patients with advanced chronic kidney disease. by Rocio Gimena Muñoz (22339634)

Subjects:

Correlation between circulating microvesicles in patients with advanced chronic kidney disease and different parameters. by Rocio Gimena Muñoz (22339634)

Subjects:

Data Sheet 1_Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease.docx by Zhifeng Gao (11229156)

Subjects:

Diagram of drug relationships associated with Significant genes. by MaoMeng Wang (22177417)

Subjects:

BIMAST score vs conventional screening methods for predicting significant and advanced fibrosis in the diabetic primary care population (whole study population). by Roberta Forlano (9499666)